The BPgWSP test: a Bayesian Weibull Shape Parameter signal detection test for adverse drug reactions

Julia Dyck; Odile Sauzet

Home/Archive/arXiv

arXiv · 2412.05463

The BPgWSP test: a Bayesian Weibull Shape Parameter signal detection test for adverse drug reactions

Julia Dyck·Odile Sauzet

View original source ↗Read source document ↗Export metadata ↓

Abstract

We develop the Bayesian Power generalized Weibull shape parameter (BPgWSP) test as statistical method for signal detection of possible drug-adverse event associations using electronic health records for pharmacovigilance. The Bayesian approach allows the incorporation of prior knowledge about the likely time of occurrence along time-to-event data. The test is based on the shape parameters of the Power generalized Weibull (PgW) distribution. When both shape parameters are equal to one, the PgW distribution reduces to an exponential distribution, yielding a constant hazard function. This is interpreted as no temporal association between drug and adverse event (AE). The BPgWSP test involves comparing a region of practical equivalence (ROPE) around one reflecting the null hypothesis with estimated credibility intervals (CI) reflecting the posterior means of the shape parameters. The decision to raise a signal is based on the CI+ROPE tests and the selected combination rule for these outcomes. The test development requires a simulation study for tuning of the ROPE and CIs to optimize specificity and sensitivity of the test. Samples are generated under various conditions, including differences in sample size, prevalence of adverse drug reactions (ADRs), and the proportion of AEs. We explore prior assumptions reflecting the belief in the presence or absence of ADRs at different points in the observation period. Various types of ROPE, CIs, and combination rules are assessed, and optimal tuning parameters are identified based on the area under the curve. The tuned BPgWSP test is illustrated in a case study in which the time-dependent correlation between the intake of bisphosphonates and four AEs is investigated.

Explore related subjects

stat.ME

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Julia Dyck, Odile Sauzet. 2024-12-06. The BPgWSP test: a Bayesian Weibull Shape Parameter signal detection test for adverse drug reactions. https://arxiv.org/abs/2412.05463

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Surprise Reduction and Nullification in Bayesian and Inverse Bayesian Inference under Ambiguous Prediction-Error Attribution

In non-stationary environments, prediction errors may signal environmental change or transient outliers, and adaptive systems must track such changes without overreacting to outliers. We distinguish surprise reduction, which updates beliefs to fit observations, from surprise nullification, which weakens constraints imposed by the predictive structure, and formalize both within Bayesian and inverse Bayesian (BIB) inference. Belief and likelihood updates are derived from variational objectives sharing a nullification strength, determined endogenously by minimizing surprise under the candidate post-update predictive distribution. In the Gaussian case, nullification expands belief and likelihood variances by a common factor relative to standard Bayesian updating, leaving the ratio unchanged. BIB thus defers attribution of the prediction error, committing to neither latent-state change nor observation-process uncertainty. The nullification strength is carried over as a candidate and is maintained or released according to the predictive surprise of the next observation. In a mean estimation task with outliers and changepoints, no scanned parameter setting of a Sage-Husa-type adaptive Kalman filter, fixed-strength BIB variant, or belief-forgetting-only variant outperforms BIB in both changepoint tracking and post-outlier stability. An oracle-informed reduced Bayesian model tracks changepoints better but is less stable after outliers. Although BIB maintains no explicit hypotheses about changepoints or outliers, it generates event-dependent dynamics. The learning rate increases after changepoints, whereas after outliers, nullification is released, and this increase is suppressed. Deferring attribution and letting subsequent observations differentiate the responses may constitute a principle of adaptive inference in non-stationary environments.

stat.ME↗

arXiv2026

Generalized Ridge Refitting for the Lasso and Prediction Improvement Bounds

We study a class of Lasso based estimators obtained by applying a quadratic correction on the Lasso equicorrelation set. The penalty matrix determines both the magnitude and geometry of the correction and contains, among other cases, the isotropic Lasso--Ridge correction, least squares refitting, Gram proportional interpolation between the Lasso and least squares, and coordinate specific penalties. We first derive a closed form representation and isolate the positive gain component of the resulting prediction improvement. We then control the remaining stochastic linear term in expectation by localizing the random signed equicorrelation model around a deterministic reference support. This yields a finite sample expectation bound that explicitly accounts for the randomness induced by Lasso model selection. The resulting decomposition provides a unified framework for understanding when Lasso based quadratic corrections can improve prediction.

stat.ME↗

arXiv2026

Discretization in covariate-adaptive randomization: gains and losses

Covariate-adaptive randomization(CAR) is widely implemented in clinical trials to balance prognostic covariates across treatment arms. Continuous covariates are often discretized into strata in practice, yet their consequences are not clearly understood. This paper provides a comprehensive study of the impact of discretization on both the CAR design process and the inferential results thereafter. We establish the asymptotic properties of both imbalance measures and treatment effect estimators under discretized and non-discretized settings. Practical recommendations are given on when and how discretization should be employed. We show that discretization in design is generally recommended, as it enhances robustness against model misspecification. However, if the true model is known, the most efficient strategy is to balance covariates according to that model in the design. The theoretical results are corroborated by extensive simulation studies and an empirical application to a diabetes trial dataset. Together, the results clarify the gains and losses of discretization in CAR and pave the way for learning impact of discretization to other designs and beyond.

stat.ME↗